Right on the Nose: IL-17C and Nasal Host Defense
- PMID: 31348675
- PMCID: PMC6938139
- DOI: 10.1165/rcmb.2019-0236ED
Right on the Nose: IL-17C and Nasal Host Defense
Comment on
-
IL-17C Protects Nasal Epithelium from Pseudomonas aeruginosa Infection.Am J Respir Cell Mol Biol. 2020 Jan;62(1):95-103. doi: 10.1165/rcmb.2018-0377OC. Am J Respir Cell Mol Biol. 2020. PMID: 31318581
References
-
- Jeon YJ, Jo A, Won J, Lee KM, Yoon SS, Choi JY, et al. IL-17C protects nasal epithelium from Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 2020;62:95–103. - PubMed
-
- Kusagaya H, Fujisawa T, Yamanaka K, Mori K, Hashimoto D, Enomoto N, et al. Toll-like receptor-mediated airway IL-17C enhances epithelial host defense in an autocrine/paracrine manner. Am J Respir Cell Mol Biol. 2014;50:30–39. - PubMed
-
- Pfeifer P, Voss M, Wonnenberg B, Hellberg J, Seiler F, Lepper PM, et al. IL-17C is a mediator of respiratory epithelial innate immune response. Am J Respir Cell Mol Biol. 2013;48:415–421. - PubMed
-
- Jin J, Rha KS, Kim DW, Kim YM. IL-17C expression in nasal epithelial cells of chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271:1097–1105. - PubMed
-
- Olcott CM, Han JK, Cunningham TD, Franzese CB. Interleukin-9 and interleukin-17C in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6:841–847. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources